Asian Factories Finish 2024 on a Shaky Note as the Risks of Trump 2.0 Loom Large

Asian Factories Finish 2024 on a...

As prospects for the New Year deteriorated due to China's shaky economic...

Kunal Kamra Targets CEO of Blinkit over Delivery Partner...

Albinder Dhindsa, CEO of Blinkit, celebrated the spike in orders on New Year's Eve by highlighting the platform's record-breaking delivery numbers. Comedian...

VP Jitendra Bagga's Resignation Marks Zepto's Second...

Jitendra Bagga, the vice-president of central operations at Zepto, quit after nine months of employment, making him the second senior executive to leave the...

The Share Price of Reliance Power in Focus Today

Reliance Power share price: When the Indian stock market begins trading on Monday, Anil Ambani's Reliance Power shares will be the focus. Reliance Power Ltd's subsidiary, Rosa Power Supply Company Limited, has secured a term loan of up to ₹3,7...

As the Talent War Rages, Experts in Artificial Intelligence Hit Pay Dirt

According to industry experts, the competition for AI talent is expected to intensify in the upcoming year as multinational corporations, global capability centers (GCCs), and IT firms vie for the top candidates in a limited labor market...

Osamu Suzuki, who Introduced the Japanese Automaker to India, Passes Away at 94

Osamu Suzuki, who Introduced the Japanese Automaker to...

At the age of 94, Osamu Suzuki, the longtime CEO of Suzuki Motor Corporation...

Jubilant Foods Inks MoU with Coca-Cola for Beverages and Food Items

Jubilant Foods Inks MoU with Coca-Cola for Beverages and...

The Indian quick-service restaurant operator Jubilant Food Ltd (JFL) has...

Manmohan Singh's Death: The Government Announces Seven-day Mourning

Manmohan Singh's Death: The Government Announces...

Manmohan Singh, 92, a former prime minister and one of India's finest...

China Intends to Build the Largest Dam in the World on the Brahmaputra

On the Brahmaputra River in Tibet, close to the Indian border, China has authorized the construction of the largest dam in the world.

Mankind Pharma and Innovent Sign a Deal for an Immunotherapy Drug in India

Mankind Pharma Ltd. and Innovent Biologics announced a collaboration to solely license and commercialize the cancer-treating immunotherapy medication Sintilimab in the Indian market.

Magazine Edition






🍪 Do you like Cookies?

We use cookies to ensure you get the best experience on our website. Read more...